ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于召开2024年年度股东会的通知 | 2025-04-28 | Chinese | |
| 2024年年度内部控制自我评价报告 | 2025-04-28 | Chinese | |
| 关于使用闲置自有资金进行现金管理的公告 | 2025-04-28 | Chinese | |
| 独立董事2024年度述职报告（张雪梅） | 2025-04-28 | Chinese | |
| 2024年度财务决算报告 | 2025-04-28 | Chinese | |
| 关于开展外汇套期保值业务的公告 | 2025-04-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36044749 | 关于召开2024年年度股东会的通知 | 2025-04-28 | Chinese | ||
| 36044739 | 2024年年度内部控制自我评价报告 | 2025-04-28 | Chinese | ||
| 36044725 | 关于使用闲置自有资金进行现金管理的公告 | 2025-04-28 | Chinese | ||
| 36044716 | 独立董事2024年度述职报告（张雪梅） | 2025-04-28 | Chinese | ||
| 36044702 | 2024年度财务决算报告 | 2025-04-28 | Chinese | ||
| 36044691 | 关于开展外汇套期保值业务的公告 | 2025-04-28 | Chinese | ||
| 36044682 | 睿智医药2025年限制性股票激励计划实施考核管理办法 | 2025-04-28 | Chinese | ||
| 36044672 | 关于2024年度不进行利润分配的专项说明公告 | 2025-04-28 | Chinese | ||
| 36044664 | 睿智医药2025年限制性股票激励计划首次授予激励对象名单 | 2025-04-28 | Chinese | ||
| 36044654 | 董事会审计委员会对会计师事务所履行监督职责情况报告 | 2025-04-28 | Chinese | ||
| 36044646 | 2024年度监事会工作报告 | 2025-04-28 | Chinese | ||
| 36044638 | 独立董事2024年度述职报告（汪献忠） | 2025-04-28 | Chinese | ||
| 36044599 | 睿智医药2025年限制性股票激励计划（草案）摘要 | 2025-04-28 | Chinese | ||
| 36044581 | 2025年一季度报告 | 2025-04-28 | Chinese | ||
| 36044564 | 2024年度会计师事务所履职情况评估报告 | 2025-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.